CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)

NB; DAN; NO3; DAND1; Differential Screening-Selected Gene Aberrant In Neuroblastoma; DAN domain family member 1

  • CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) Packages (Simulation)
  • CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) Packages (Simulation)
  • CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) Results demonstration
  • SCP853Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)

This assay has high sensitivity and excellent specificity for detection of Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1).
No significant cross-reactivity or interference between Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) and analogues was observed.

Precision of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Stability of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)

The microplate provided in this kit has been pre-coated with an antibody specific to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPP853Hu01 Recombinant Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) Positive Control; Immunogen; SDS-PAGE; WB.
PAP853Hu01 Polyclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) WB; IHC; ICC; IP.
MAP853Hu21 Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) WB; IHC; ICC; IP.
SEP853Hu ELISA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCP853Hu CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) Chemiluminescent immunoassay for Antigen Detection.
LMP853Hu Multiplex Assay Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CGP853Hu01 cDNA of Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) PCR; Protein Expression; etc.
GUESTBOOK